About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Houston | 372 Studies

Clinical Trials HypertensionHouston

Hypertension Clinical Trials in Houston

Find 372 clinical trials for hypertension near Houston, Texas. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-360 of 372 trials

CompletedEfficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic HypertensionThis study will evaluate the safety and efficacy of first-line treatment with a free combination (as two separate pills) of nebivolol and lisinopril in patients with stage 2…NCT01218100·Scottsdale, Arizona and 89 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTelmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe HypertensionThe primary objective of this trial is to demonstrate that the fixed-dose combination of T80/HCTZ25 is superior as first line therapy in reducing seated trough cuff Systolic Blood…NCT00926289·Athens, Alabama and 105 others

CompletedA Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II PatientsThe primary objective of this study is to compare the effectiveness of telmisartan 80 mg/hydrochlorothiazide 25 mg \[Micardis HCT\] to valsartan 160 mg/hydrochlorothiazide 25 mg…NCT00240448·Birmingham, Alabama and 99 others

CompletedEvaluation of ETC-1002 in Participants With Hypercholesterolemia and HypertensionThis Phase 2 study will assess the efficacy and safety of ETC-1002 monotherapy versus placebo in participants with hypercholesterolemia and hypertension.NCT02178098·Birmingham, Alabama and 42 others

TerminatedThe American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)Outcomes of subjects with uncontrolled glaucoma with a single existing aqueous tube shunt implant undergoing a second aqueous shunt to transscleral diode laser…NCT02691455·La Jolla, California and 22 others

CompletedFiribastat in Treatment-resistant HypertensionThis is a double-blind, placebo-controlled, multicenter, efficacy and safety study of firibastat (QGC001) administered po bid over 12 weeks in male and female subjects ≥18 years…NCT04277884·Birmingham, Alabama and 19 others

Completed8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With HypertensionThe purpose of this study is to evaluate the effect of food on aliskiren's efficacy, pharmacokinetics and safety following an oral dose of 300 mg, given once daily under light…NCT01570686·Los Angeles, California and 82 others

CompletedStudy to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial HypertensionThis study enrolls patients with pulmonary arterial hypertension (PAH) treated with inhaled treprostinil.NCT02471183·La Jolla, California and 14 others

RecruitingPulmonary Hypertension Association RegistryThe PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).NCT04071327·Phoenix, Arizona and 51 others

Active not recruitingA Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive PatientsThe purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients…NCT06857955·Andalusia, Alabama and 72 others

CompletedAdditivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to TravatanThe purpose of this study is to compare the additive effect on eye pressure of Azopt and Alphagan P to Travatan.NCT00121147·Los Angeles, California and 20 others

CompletedThe IMPULSE Study: PilotContinuous-flow (CF) left ventricular assist devices (LVADs) are an important tool in the treatment of end-stage heart failure, affording patients significantly improved quantity…NCT02044471·Houston, Texas

CompletedRituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)Systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) is a serious, life-threatening manifestation of systemic sclerosis (SSc), an autoimmune disease of the…NCT01086540·Stanford, California and 16 others

CompletedEfficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of HypertensionRecent hypertension guidelines recommend combination therapy as initial treatment for many or most patients.NCT04518293·Phoenix, Arizona and 88 others

CompletedAssessmet of Patients With PAH Right Ventricular VolumeThe primary endpoint of this study is the percent difference between the VentriPoint Medical System (VMS) and cMRI for estimating the end diastolic and end systolic right…NCT01557582·Chicago, Illinois and 6 others

CompletedPulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier DetectionStudy GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial…NCT05776225·Phoenix, Arizona and 41 others

CompletedRheos® Pivotal TrialThe purpose of this clinical trial is to demonstrate the efficacy and safety of the Rheos system in subjects with hypertension that are resistant to treatment with at least three…NCT00442286·Birmingham, Alabama and 43 others

CompletedAssessing the Feasibility of N-of-1 Trials in Children With Hypertension and Chronic Kidney DiseaseThe purpose of this study to test whether n-of-1 trial-guided clinical decision-making improves blood pressure control in hypertensive children with chronic kidney disease (CKD)…NCT04591171·Houston, Texas

CompletedA 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaTo demonstrate statistical superiority of the combination of latanoprost and timolol to the individual therapy of latanoprost and timolol based on intraocular pressure…NCT00277498·Birmingham, Alabama and 63 others

CompletedAtacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of AgeStudy 261A is a dose-ranging and safety study of candesartan cilexetil.NCT00244634·Beverly Hills, California and 43 others

PreviousPage 18 of 19Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia